5/15/2012NDRC to Introduce a New Guideline for Reform of Drug Prices at County ...

5/15/2012Health Minister Chen Zhu: China to Promote Use of Advanced Biopharma P...

5/15/2012Recent Executive Moves

5/15/2012BMS Enters Strategic Partnership with Tsinghua U for Drug Discovery

5/14/2012Data Snapshot: Chinese Market Shares by Dosage Forms with Emphasis on ...

5/14/2012The MOH Holds Annual Clinical Pathway Management Conference

5/11/2012WuXi PharmaTech Reports Sharp Revenue Growth in Q1 2012

5/10/2012Government to Formulate New Incentive Policies for Pharma Industry Con...

5/10/2012Merck to Launch VYTORIN (Ezetimibe/Simvastatin) Tablets in China

5/10/2012Simcere Pharma Reports Flat Performance in 1Q

5/10/2012Novozymes Begins Supply of Hyaluronic Acid from China

5/9/2012Hanmi Acquires China and Korean Rights of DZNS from SK Biopharma

5/9/2012Review of Chinese Pharmaceutical Industry Performance in 2011

5/7/2012Two Core Pharmaceutical Subsidiaries under Genertec to Merge

5/7/2012Celsion and Hisun Enter Supply Agreement for ThermoDox

5/4/2012Chinese Central Government to Be Reorganized and Consolidated after 18...

5/4/2012Chinese Pharma Industry Continues Steady Growth in the First Quarter

5/4/2012Latest Executive Moves

5/4/2012J&J China Takes over Private-Held Biopharma Firm Guangzhou Bioseal

5/2/2012MOF Demands for Increased Government Healthcare Investment to Ensure R...

5/2/2012Shanghai to Eliminate "Financing Hospitals with Drug Revenues&quo...

4/30/2012Update on International Regulatory Compliance of China-based Pharma Co...

4/30/2012SFDA Approves Chinese-developed Manidipine

4/26/2012MOH Gets a Budget Boost in 2012

4/26/2012China Support Contract Management of NRCMS by Commercial Insurance Fir...

4/25/2012SFDA Issues Clarifications on Enforcement of GMP 2010 for Ophthalmolog...

4/24/2012SK Biopharm and Hanmi Enter Licensing Deal for China and Korean Rights...

4/24/2012MicuRx Pharmaceuticals Completes Phase I Trial for New Antibiotic MRX-...

4/24/2012Recent Executive Moves

4/23/2012Chinese Biopharma Public Companies Underperformed in 2011

Page:283/361 Total number of articles:10807: [First][<<] [281] [282] [283] [284] [285] [>>] [End]